Luluca Capsule 150 mg (Pregabalin)

Adult dose

This medication should be administered orally, in two divided doses per day, without regard to food. 1. Neuropathic Pain 1) Peripheral Neuropathic Pain: Starting dose is 150 mg per day; it may be increased to 300 mg per day within 3 to 7 days, and may further be increased to a maximum of 600 mg per day at 7-day intervals. 2) Central Neuropathic Pain: Starting dose is 150 mg per day; after one week.

Child dose

The use of this medication is not recommended in children under 12 years of age and in adolescents aged 12 to 17 years due to insufficient safety and efficacy data.

This medication is utilized as an antiepileptic drug, and the risk of suicidal thoughts, suicidal behavior, or changes in mental health such as depression may increase during use, so it is important to inform medical personnel immediately if these symptoms appear. Patients with allergies to the components of this medication, or with specific genetic issues such as lactose intolerance, should not take it. Diabetic patients may need to adjust the dosage of their blood glucose control medications due to weight gain, and if symptoms of angioedema such as swelling of the face or around the mouth appear during medication, they should stop taking the medication immediately. Elderly patients need to be cautious as symptoms like dizziness, drowsiness, or loss of consciousness may occur; vision changes such as blurred sight have also been reported, and they should consult with medical personnel if these symptoms occur. Abruptly stopping this medication may cause withdrawal symptoms such as insomnia, headaches, and anxiety, so dosage should be tapered gradually following medical advice. Patients with a history of substance abuse should take special care to avoid misuse or dependence on this medication and should observe for signs of substance abuse. Patients with impaired kidney function may need dosage adjustments, and those with severe heart disease should use caution when taking this medication. Taking this medication in combination with other drugs that have central nervous system depressant effects may increase the risk of respiratory depression, so special care should be taken especially when taken with opioid analgesics. In early pregnancy, there is a risk of fetal malformation, so women who are pregnant or planning to become pregnant should consult with medical personnel before taking this medication and are encouraged to use effective contraception. During breastfeeding, this medication may transfer into breast milk and affect the infant, so it is necessary to discuss breastfeeding and medication use with medical personnel. Activities requiring attentiveness, such as driving or operating machinery, should be avoided until symptoms of dizziness or drowsiness completely resolve after taking this medication. In case of overdose, symptoms such as confusion, drowsiness, or depression may occur, and immediate medical attention should be sought, as treatments such as hemodialysis may be necessary.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden severe headaches, lightning-like headaches, seizures, confusion of consciousness, vision abnormalities, paralysis.

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoric mood
• decreased libido
• insomnia
• depersonalization

This medication is sensitive to air and humidity, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 15 and 30 degrees Celsius.

Appearance

A hard capsule with white upper and lower parts containing a powder that is white to pale yellow.

Package unit

30 capsules/bottle